Gilead Sciences Company Profile (NASDAQ:GILD)

About Gilead Sciences

Gilead Sciences logoGilead Sciences, Inc. is a research-based biopharmaceutical company. The Company focuses on the discovery, development and commercialization of medicines in areas of unmet medical need. The Company's principal areas of focus include human immunodeficiency virus (HIV), liver diseases, such as chronic hepatitis C virus infection and chronic hepatitis B virus infection, cardiovascular, hematology/oncology and inflammation/respiratory. Its HIV products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost and Vitekta. The Company's liver diseases products include Harvoni, Sovaldi, Viread and Hepsera. The Company's cardiovascular products include Letairis, Ranexa and Lexiscan/Rapiscan. Its oncology product is Zydelig. Its respiratory products include Cayston and Tamiflu. Its other products include AmBisome and Macugen. The Company's Nimbus Apollo program is a Phase II ready clinical program for NDI-010976 and related metabolic and liver diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GILD
  • CUSIP: 37555810
Key Metrics:
  • Previous Close: $80.50
  • 50 Day Moving Average: $82.74
  • 200 Day Moving Average: $87.35
  • Trailing P/E Ratio: 7.07
  • Foreward P/E Ratio: 6.89
  • P/E Growth: 85.88
  • Market Cap: $106.23B
  • Outstanding Shares: 1,319,658,000
  • Beta: 1.07
Additional Links:
Companies Related to Gilead Sciences:

Analyst Ratings

Consensus Ratings for Gilead Sciences (NASDAQ:GILD) (?)
Ratings Breakdown: 9 Hold Ratings, 16 Buy Ratings, 2 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.74)
Consensus Price Target: $107.72 (33.82% upside)

Analysts' Ratings History for Gilead Sciences (NASDAQ:GILD)
Show:
DateFirmActionRatingPrice TargetDetails
8/24/2016Leerink SwannReiterated RatingOutperform$114.00 -> $112.00View Rating Details
8/21/2016Piper Jaffray Cos.Set Price TargetBuy$108.00View Rating Details
8/11/2016RBC Capital MarketsSet Price TargetBuy$105.00View Rating Details
8/1/2016Jefferies GroupReiterated RatingHold$93.00View Rating Details
7/29/2016ArgusDowngradeBuy -> Hold$88.00 -> $81.00View Rating Details
7/28/2016Barclays PLCReiterated RatingOverweightView Rating Details
7/27/2016Maxim GroupSet Price TargetHold$88.55View Rating Details
7/27/2016BMO Capital MarketsReiterated RatingMarket Perform$97.00 -> $98.00View Rating Details
7/27/2016S&P Equity ResearchReiterated RatingStrong-BuyView Rating Details
7/26/2016Credit Suisse Group AGReiterated RatingBuy$120.00 -> $115.00View Rating Details
7/26/2016Robert W. BairdReiterated RatingOutperform$135.00 -> $122.00View Rating Details
7/26/2016Needham & Company LLCDowngradeBuy -> Hold$84.60 -> $88.55View Rating Details
7/26/2016Royal Bank Of CanadaLower Price TargetOutperform$120.00 -> $105.00View Rating Details
7/5/2016Cowen and CompanyReiterated RatingOutperform$125.00View Rating Details
6/15/2016Morgan StanleyReiterated RatingHold$103.00View Rating Details
6/1/2016GabelliInitiated CoverageBuy$109.00View Rating Details
5/31/2016Citigroup Inc.Reiterated RatingBuy$105.00View Rating Details
5/14/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
5/4/2016Oppenheimer Holdings Inc.Reiterated RatingBuy$120.00 -> $116.00View Rating Details
4/10/2016MizuhoReiterated RatingBuy$130.00View Rating Details
3/31/2016Bank of America Corp.Reiterated RatingNeutral$104.00View Rating Details
2/22/2016Goldman Sachs Group Inc.Lower Price Target$91.00 -> $87.00View Rating Details
2/5/2016Evercore ISIReiterated RatingBuy$115.00View Rating Details
2/3/2016Standpoint ResearchInitiated CoverageBuy$110.00View Rating Details
2/1/2016William BlairReiterated RatingOutperformView Rating Details
1/22/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details
12/18/2015Atlantic SecuritiesInitiated CoverageNeutral$111.00View Rating Details
9/10/2015Jyske BankUpgradeStrong-Buy$125.00View Rating Details
8/7/2015Stifel NicolausDowngradeHoldView Rating Details
7/29/2015Deutsche Bank AGBoost Price Target$125.00 -> $135.00View Rating Details
5/29/2015Sanford C. BernsteinReiterated RatingOutperform$125.00View Rating Details
2/27/2015NomuraSet Price TargetBuy$141.00View Rating Details
10/31/2014Edward JonesInitiated CoverageHoldView Rating Details
10/13/2014FBR & CoBoost Price TargetOutperform$125.00 -> $130.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Gilead Sciences (NASDAQ:GILD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
7/25/2016Q216$3.02$3.08$7.80 billion$7.78 billionViewListenView Earnings Details
4/28/2016Q116$3.13$3.03$8.08 billion$7.80 billionViewListenView Earnings Details
2/2/2016Q415$3.00$3.32$8.11 billion$8.51 billionViewListenView Earnings Details
10/27/2015Q315$2.87$3.22$7.84 billion$8.30 billionViewListenView Earnings Details
7/28/2015Q215$2.83$3.15$7.60 billion$8.22 billionViewListenView Earnings Details
4/30/2015Q115$2.32$2.94$6.81 billion$7.59 billionViewListenView Earnings Details
2/3/2015Q414$2.19$2.43$6.68 million$7.31 billionViewListenView Earnings Details
10/28/2014Q314$1.92$1.84$5.99 billion$6.04 billionViewListenView Earnings Details
7/23/2014Q214$1.73$2.36$5.68 billion$6.53 billionViewListenView Earnings Details
4/22/2014Q114$0.85$1.48$3.80 billion$5.00 billionViewListenView Earnings Details
2/4/2014Q413$0.50$0.55$2.85 billion$3.04 billionViewListenView Earnings Details
10/29/2013Q313$0.48$0.52$2.72 billion$2.78 billionViewListenView Earnings Details
7/25/2013Q2 2013$0.50$0.50$2.66 billion$2.77 billionViewListenView Earnings Details
5/2/2013Q1 2013$0.50$0.48$2.57 billion$2.53 billionViewListenView Earnings Details
2/4/2013Q4 2012$0.48$0.50$2.43 billion$2.59 billionViewListenView Earnings Details
10/23/2012$0.94$1.00ViewN/AView Earnings Details
7/26/2012$0.95$0.99ViewN/AView Earnings Details
4/26/2012$0.94$0.91ViewN/AView Earnings Details
2/2/2012$1.04$0.97ViewN/AView Earnings Details
10/27/2011$1.01$1.02ViewN/AView Earnings Details
4/20/2011$0.97$0.87ViewN/AView Earnings Details
1/25/2011$0.95$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Gilead Sciences (NASDAQ:GILD)
Current Year EPS Consensus Estimate: $11.78 EPS
Next Year EPS Consensus Estimate: $11.69 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$2.88$3.29$3.06
Q2 20162$3.03$3.25$3.14
Q3 20164$2.79$3.04$2.95
Q4 20163$2.85$3.01$2.92
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Gilead Sciences (NASDAQ:GILD)
Annual Dividend:$1.88
Dividend Yield:2.34%
Payout Ratio:16.56% (Based on Trailing 12 Months of Earnings)
15.96% (Based on Current Year Consensus EPS Estimate)
16.08% (Based on Next Year Consensus EPS Estimate)

Dividend History for Gilead Sciences (NASDAQ:GILD)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/25/2016quarterly$0.472.32%9/14/20169/16/20169/29/2016
4/28/2016quarterly$0.472.13%6/14/20166/16/20166/29/2016
2/2/2016quarterly$0.431.99%3/14/20163/16/20163/30/2016
10/27/2015quarterly$0.431.59%12/14/201512/16/201512/30/2015
7/28/2015quarterly$0.431.49%9/14/20159/16/20159/29/2015
4/30/2015quarterly$0.436/12/20156/16/20156/29/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Gilead Sciences (NASDAQ:GILD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/1/2016John C MartinInsiderSell100,000$80.50$8,050,000.00View SEC Filing  
8/1/2016Paul Rutherford CarterEVPSell2,000$79.81$159,620.00View SEC Filing  
7/5/2016John F MilliganCEOSell112,000$84.33$9,444,960.00View SEC Filing  
7/1/2016John C MartinChairmanSell100,000$84.73$8,473,000.00View SEC Filing  
7/1/2016Paul Rutherford CarterEVPSell2,000$83.12$166,240.00View SEC Filing  
6/6/2016John F MilliganCEOSell112,000$86.94$9,737,280.00View SEC Filing  
6/1/2016Paul Rutherford CarterEVPSell2,000$87.02$174,040.00View SEC Filing  
5/2/2016John C MartinChairmanSell100,000$87.82$8,782,000.00View SEC Filing  
5/2/2016John F MilliganCEOSell112,000$87.71$9,823,520.00View SEC Filing  
5/2/2016Paul Rutherford CarterEVPSell2,000$88.72$177,440.00View SEC Filing  
4/19/2016Gregg H AltonEVPSell40,000$100.01$4,000,400.00View SEC Filing  
4/4/2016John F MilliganCEOSell112,000$94.59$10,594,080.00View SEC Filing  
4/1/2016John C MartinChairmanSell100,000$93.24$9,324,000.00View SEC Filing  
4/1/2016Paul Rutherford CarterEVPSell2,000$91.34$182,680.00View SEC Filing  
3/14/2016Gregg H AltonEVPSell5,000$90.00$450,000.00View SEC Filing  
2/26/2016Gayle E WilsonDirectorSell6,650$90.61$602,556.50View SEC Filing  
2/1/2016John C. MartinCEOSell100,000$83.42$8,342,000.00View SEC Filing  
2/1/2016Paul Rutherford CarterEVPSell2,000$82.32$164,640.00View SEC Filing  
1/4/2016John C. MartinCEOSell100,000$97.68$9,768,000.00View SEC Filing  
1/4/2016Paul Rutherford CarterEVPSell2,000$99.20$198,400.00View SEC Filing  
12/15/2015Norbert W. BischofbergerEVPSell70,000$102.41$7,168,700.00View SEC Filing  
12/7/2015John F. MilliganCOOSell100,000$103.18$10,318,000.00View SEC Filing  
11/24/2015John Francis CoganDirectorSell15,000$105.95$1,589,250.00View SEC Filing  
11/2/2015Gregg H. AltonEVPSell12,000$109.38$1,312,560.00View SEC Filing  
11/2/2015John C. MartinCEOSell150,000$109.42$16,413,000.00View SEC Filing  
11/2/2015Robin L WashingtonCFOSell6,250$109.46$684,125.00View SEC Filing  
10/27/2015John Francis CoganDirectorSell15,000$110.00$1,650,000.00View SEC Filing  
10/26/2015Gregg H. AltonEVPSell5,000$110.00$550,000.00View SEC Filing  
10/26/2015John Francis CoganDirectorSell15,000$110.00$1,650,000.00View SEC Filing  
10/15/2015Norbert W. BischofbergerEVPSell70,000$100.05$7,003,500.00View SEC Filing  
10/7/2015John F. MilliganCOOSell100,000$99.22$9,922,000.00View SEC Filing  
10/5/2015Gregg H. AltonEVPSell5,000$100.00$500,000.00View SEC Filing  
10/1/2015John C. MartinCEOSell150,000$97.48$14,622,000.00View SEC Filing  
10/1/2015Paul Rutherford CarterEVPSell2,000$98.59$197,180.00View SEC Filing  
9/15/2015Gregg H. AltonEVPSell5,000$110.00$550,000.00View SEC Filing  
9/15/2015John Francis CoganDirectorSell15,000$110.00$1,650,000.00View SEC Filing  
9/8/2015John F. MilliganCOOSell100,000$103.39$10,339,000.00View SEC Filing  
9/2/2015Robin L WashingtonCFOSell6,250$102.20$638,750.00View SEC Filing  
9/1/2015John C. MartinCEOSell150,000$102.73$15,409,500.00View SEC Filing  
8/28/2015Gayle E. WilsonDirectorSell21,000$106.96$2,246,160.00View SEC Filing  
8/25/2015John C. MartinCEOSell133,213$105.17$14,010,011.21View SEC Filing  
8/17/2015Norbert W BischofbergerEVPSell70,000$116.16$8,131,200.00View SEC Filing  
7/7/2015John F MilliganCOOSell100,000$114.44$11,444,000.00View SEC Filing  
6/26/2015John Francis CoganDirectorSell27,000$120.13$3,243,510.00View SEC Filing  
6/18/2015Paul Rutherford CarterEVPSell10,000$120.00$1,200,000.00View SEC Filing  
6/15/2015Norbert W BischofbergerEVPSell70,000$117.67$8,236,900.00View SEC Filing  
6/8/2015John F MilliganCOOSell100,000$114.05$11,405,000.00View SEC Filing  
6/1/2015Gregg H AltonEVPSell17,000$113.64$1,931,880.00View SEC Filing  
6/1/2015John C MartinCEOSell150,000$113.95$17,092,500.00View SEC Filing  
4/15/2015Norbert W BischofbergerEVPSell70,000$103.84$7,268,800.00View SEC Filing  
4/8/2015Paul Rutherford CarterEVPSell1,000$100.00$100,000.00View SEC Filing  
4/1/2015Gregg H AltonEVPSell7,000$96.53$675,710.00View SEC Filing  
4/1/2015John C MartinCEOSell150,000$96.74$14,511,000.00View SEC Filing  
3/2/2015John C MartinCEOSell150,000$103.51$15,526,500.00View SEC Filing  
3/2/2015Paul Rutherford CarterEVPSell2,000$104.18$208,360.00View SEC Filing  
3/2/2015Richard James WhitleyDirectorSell5,000$103.43$517,150.00View SEC Filing  
2/6/2015Olsen Per WoldDirectorBuy10,000$99.92$999,200.00View SEC Filing  
2/2/2015Gregg H AltonEVPSell12,000$105.73$1,268,760.00View SEC Filing  
2/2/2015John C MartinCEOSell150,000$105.43$15,814,500.00View SEC Filing  
2/2/2015Robin L WashingtonCFOSell33,192$105.38$3,497,772.96View SEC Filing  
1/15/2015Norbert W BischofbergerEVPSell70,000$98.47$6,892,900.00View SEC Filing  
1/8/2015Gregg H AltonEVPSell5,000$100.89$504,450.00View SEC Filing  
1/5/2015John C MartinCEOSell150,000$95.12$14,268,000.00View SEC Filing  
1/2/2015Gregg H AltonEVPSell7,000$95.17$666,190.00View SEC Filing  
1/2/2015Richard James WhitleyDirectorSell5,000$95.22$476,100.00View SEC Filing  
12/22/2014John Francis CoganDirectorSell26,000$95.03$2,470,780.00View SEC Filing  
12/8/2014John F MilliganCOOSell146,823$106.26$15,601,411.98View SEC Filing  
12/1/2014John C MartinCEOSell140,633$100.72$14,164,555.76View SEC Filing  
12/1/2014Paul Rutherford CarterEVPSell2,000$100.02$200,040.00View SEC Filing  
11/3/2014John C MartinCEOSell140,625$110.40$15,525,000.00View SEC Filing  
11/3/2014Richard James WhitleyDirectorSell5,000$112.02$560,100.00View SEC Filing  
11/3/2014Robin L WashingtonCFOSell33,192$110.26$3,659,749.92View SEC Filing  
10/24/2014Paul Rutherford CarterEVPSell2,000$110.00$220,000.00View SEC Filing  
10/7/2014John F MilliganCOOSell146,895$104.60$15,365,217.00View SEC Filing  
10/1/2014John C MartinCEOSell140,625$105.91$14,893,593.75View SEC Filing  
10/1/2014Paul Rutherford CarterEVPSell2,000$106.39$212,780.00View SEC Filing  
10/1/2014Richard James WhitleyDirectorSell5,000$106.99$534,950.00View SEC Filing  
9/26/2014Paul Rutherford CarterEVPSell2,000$107.47$214,940.00View SEC Filing  
9/22/2014John Francis CoganDirectorSell5,000$106.60$533,000.00View SEC Filing  
9/8/2014John F MilliganCOOSell146,895$105.99$15,569,401.05View SEC Filing  
9/2/2014Gregg H AltonEVPSell33,000$108.58$3,583,140.00View SEC Filing  
9/2/2014John C MartinCEOSell140,625$108.64$15,277,500.00View SEC Filing  
8/26/2014Paul Rutherford CarterEVPSell10,000$106.16$1,061,600.00View SEC Filing  
8/25/2014Robin L WashingtonCFOSell4,304$105.87$455,664.48View SEC Filing  
8/21/2014John Francis CoganDirectorSell5,000$101.09$505,450.00View SEC Filing  
8/14/2014Robin L WashingtonCFOSell33,556$95.56$3,206,611.36View SEC Filing  
8/1/2014Gregg H AltonEVPSell33,000$91.62$3,023,460.00View SEC Filing  
8/1/2014John C MartinCEOSell140,625$91.53$12,871,406.25View SEC Filing  
8/1/2014Richard James WhitleyDirectorSell5,000$91.00$455,000.00View SEC Filing  
8/1/2014Robin L WashingtonCFOSell30,600$91.48$2,799,288.00View SEC Filing  
7/28/2014Nicholas G MooreDirectorSell45,000$90.56$4,075,200.00View SEC Filing  
7/21/2014John Francis CoganDirectorSell5,000$89.67$448,350.00View SEC Filing  
7/8/2014Paul Rutherford CarterEVPSell16,728$86.45$1,446,135.60View SEC Filing  
7/1/2014Gregg H AltonEVPSell33,000$84.12$2,775,960.00View SEC Filing  
7/1/2014John C MartinCEOSell140,625$84.84$11,930,625.00View SEC Filing  
7/1/2014Richard James WhitleyDirectorSell5,000$83.65$418,250.00View SEC Filing  
6/30/2014Robin L WashingtonCFOSell10,400$83.98$873,392.00View SEC Filing  
6/23/2014John Francis CoganDirectorSell5,000$81.82$409,100.00View SEC Filing  
6/16/2014Norbert W BischofbergerEVPSell90,000$80.90$7,281,000.00View SEC Filing  
6/9/2014Paul Rutherford CarterEVPSell16,728$79.43$1,328,705.04View SEC Filing  
6/4/2014Robin L WashingtonCFOSell6,426$82.52$530,273.52View SEC Filing  
6/2/2014Gregg H AltonEVPSell33,000$81.35$2,684,550.00View SEC Filing  
6/2/2014Richard James WhitleyDirectorSell5,000$80.95$404,750.00View SEC Filing  
5/14/2014Norbert BischofbergerEVPSell90,000$80.65$7,258,500.00View SEC Filing  
5/6/2014Robin WashingtonCFOSell3,000$79.91$239,730.00View SEC Filing  
5/1/2014Gregg AltonEVPSell13,000$79.08$1,028,040.00View SEC Filing  
5/1/2014John MartinCEOSell140,625$79.02$11,112,187.50View SEC Filing  
5/1/2014Richard James WhitleyDirectorSell5,000$78.63$393,150.00View SEC Filing  
5/1/2014Robin WashingtonCFOSell27,600$79.16$2,184,816.00View SEC Filing  
4/14/2014Norbert BischofbergerEVPSell90,000$67.03$6,032,700.00View SEC Filing  
4/8/2014John Francis CoganDirectorSell5,000$70.55$352,750.00View SEC Filing  
4/8/2014Paul Rutherford CarterEVPSell16,728$70.53$1,179,825.84View SEC Filing  
4/1/2014Gregg AltonEVPSell13,000$73.20$951,600.00View SEC Filing  
4/1/2014John MartinCEOSell140,625$73.26$10,302,187.50View SEC Filing  
3/14/2014John Francis CoganDirectorSell14,000$76.44$1,070,160.00View SEC Filing  
3/14/2014Norbert BischofbergerEVPSell90,000$75.89$6,830,100.00View SEC Filing  
3/10/2014Paul Rutherford CarterEVPSell16,728$79.32$1,326,864.96View SEC Filing  
3/3/2014Gregg AltonEVPSell33,000$81.84$2,700,720.00View SEC Filing  
3/3/2014John MartinCEOSell140,625$81.74$11,494,687.50View SEC Filing  
2/26/2014Nicholas MooreDirectorSell20,000$84.05$1,681,000.00View SEC Filing  
2/19/2014Nicholas MooreDirectorSell19,068$83.12$1,584,932.16View SEC Filing  
1/23/2014Kevin YoungEVPSell100,000$81.44$8,144,000.00View SEC Filing  
1/21/2014Gregg AltonEVPSell120,000$80.00$9,600,000.00View SEC Filing  
1/14/2014Norbert BischofbergerEVPSell90,000$74.23$6,680,700.00View SEC Filing  
10/23/2013Kevin YoungEVPSell75,000$68.56$5,142,000.00View SEC Filing  
10/14/2013Norbert BischofbergerEVPSell90,000$62.54$5,628,600.00View SEC Filing  
9/23/2013Kevin YoungEVPSell100,000$62.88$6,288,000.00View SEC Filing  
9/16/2013Norbert BischofbergerEVPSell90,000$63.11$5,679,900.00View SEC Filing  
9/3/2013Gregg AltonEVPSell30,000$60.99$1,829,700.00View SEC Filing  
9/3/2013John MartinCEOSell282,242$60.97$17,208,294.74View SEC Filing  
8/30/2013Nicholas MooreDirectorSell151,720$60.42$9,166,922.40View SEC Filing  
8/14/2013Norbert BischofbergerEVPSell90,000$58.77$5,289,300.00View SEC Filing  
8/1/2013Gregg H AltonEVPSell30,000$61.49$1,844,700.00View SEC Filing  
8/1/2013John C MartinCEOSell282,242$61.61$17,388,929.62View SEC Filing  
7/30/2013John W MadiganDirectorSell249,000$61.97$15,430,530.00View SEC Filing  
7/15/2013Norbert W BischofbergerEVPSell90,000$57.33$5,159,700.00View SEC Filing  
7/2/2013John Francis CoganDirectorSell17,000$51.66$878,220.00View SEC Filing  
7/1/2013Gregg H AltonEVPSell30,000$52.09$1,562,700.00View SEC Filing  
7/1/2013John C MartinCEOSell282,242$52.00$14,676,584.00View SEC Filing  
7/1/2013Robin L WashingtonCFOSell45,600$52.01$2,371,656.00View SEC Filing  
6/7/2013John Francis CoganDirectorSell110,000$52.15$5,736,500.00View SEC Filing  
6/3/2013Gregg H AltonEVPSell30,000$52.77$1,583,100.00View SEC Filing  
6/3/2013John C MartinCEOSell282,242$52.84$14,913,667.28View SEC Filing  
2/28/2013Olsen Per WoldDirectorBuy10,000$43.05$430,500.00View SEC Filing  
12/3/2012Gregg H AltonEVPSell44,000$75.10$3,304,400.00View SEC Filing  
12/3/2012John C MartinCEOSell291,000$75.01$21,827,910.00View SEC Filing  
11/12/2012Robin L WashingtonCFOSell55,950$73.11$4,090,504.50View SEC Filing  
10/3/2012John F MilliganCOOSell140,000$69.85$9,779,000.00View SEC Filing  
10/2/2012Robin L WashingtonCFOSell29,500$68.62$2,024,290.00View SEC Filing  
9/4/2012Gregg H AltonEVPSell44,000$57.50$2,530,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Gilead Sciences (NASDAQ:GILD)
DateHeadline
thecountrycaller.com logoGilead Sciences, Inc (GILD) Price Target Slightly Reduced At Leerink To Accommodate Recent Changes (NASDAQ:GILD)
www.thecountrycaller.com - August 24 at 5:07 PM
smarteranalyst.com logoPiper Jaffray’s Take on Gilead Sciences, Inc. (GILD) Amid HIV/HCV Franchise Debate (NASDAQ:GILD)
www.smarteranalyst.com - August 24 at 5:07 PM
News IconGilead Sciences Inc. (NASDAQ:GILD) from Biotechnology – Todays Top Gains (NASDAQ:GILD)
twincountynews.com - August 24 at 5:07 PM
thestreet.com logoGilead Sciences Shares Slide on Leerink Price Target Cut (NASDAQ:GILD)
www.thestreet.com - August 24 at 5:06 PM
fool.com logoWhy You Should (and Shouldn't) Buy Gilead Sciences, Inc. (NASDAQ:GILD)
www.fool.com - August 24 at 8:15 AM
News IconTraders Alert - Gilead Sciences, Inc. (NASDAQ:GILD), Palo Alto Networks Inc (NYSE:PANW) - Money News (press release) (NASDAQ:GILD)
www.newsismoney.com - August 23 at 5:23 PM
smarteranalyst.com logoPiper Jaffray's Take on Gilead Sciences, Inc. (GILD) Amid HIV/HCV Franchise Debate - Smarter Analyst (NASDAQ:GILD)
www.smarteranalyst.com - August 23 at 5:22 PM
blogs.barrons.com logoPfizer & Medivation: A Big Win Like Gilead-Pharmasset or a Big Bust Like Bristol-Inhibitex? (NASDAQ:GILD)
blogs.barrons.com - August 23 at 5:22 PM
biz.yahoo.com logoGILEAD SCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:GILD)
biz.yahoo.com - August 23 at 5:22 PM
thecountrycaller.com logoGilead Sciences, Inc. (GILD): European Union Approved HIV Molecule - TCC (NASDAQ:GILD)
www.thecountrycaller.com - August 23 at 9:37 AM
publicnow.com logoKelly A. Kramer Joins Gilead Sciences’ Board of Directors (NASDAQ:GILD)
www.publicnow.com - August 23 at 9:37 AM
thecountrycaller.com logoIs Gilead Sciences, Inc. (NASDAQ:GILD) Stock: A Buy? - TCC (NASDAQ:GILD)
www.thecountrycaller.com - August 22 at 5:17 PM
thecountrycaller.com logoIs Gilead Sciences, Inc. (NASDAQ:GILD) Stock: A Buy? - TCC (NASDAQ:GILD)
www.thecountrycaller.com - August 22 at 5:17 PM
investors.com logoPfizer Will Buy Cancer Drugmaker Medivation For $14 Billion (NASDAQ:GILD)
www.investors.com - August 22 at 9:53 AM
thecountrycaller.com logoPiper Jaffray Explains Why Dividing Gilead Sciences, Inc. (GILD) is a Bad Bet (NASDAQ:GILD)
www.thecountrycaller.com - August 21 at 4:48 PM
fool.com logoTop Undervalued Stocks to Buy in 2016 (NASDAQ:GILD)
www.fool.com - August 21 at 4:48 PM
cnbc.com logoHere's why prescription drug costs are on the rise (NASDAQ:GILD)
www.cnbc.com - August 21 at 4:48 PM
seekingalpha.com logoGilead Can Bounce - Seeking Alpha (NASDAQ:GILD)
seekingalpha.com - August 21 at 9:39 AM
News IconIs Gilead Sciences Stock A Buy After The Recent Correction? (NASDAQ:GILD)
amigobulls.com - August 20 at 9:25 AM
News IconBiotechnology: Gilead Sciences Inc. (NASDAQ:GILD) Position of the day (NASDAQ:GILD)
twincountynews.com - August 20 at 9:25 AM
News IconShould You Buy Gilead Sciences, Inc. (NASDAQ:GILD)? - Amigobulls - Amigobulls (NASDAQ:GILD)
amigobulls.com - August 19 at 5:09 PM
News IconBiotech Stocks Worth a Closer Look: StemCells Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:GILD)
voiceregistrar.com - August 19 at 8:07 AM
News IconQuality at a Low Cost (NASDAQ:GILD)
news.morningstar.com - August 19 at 8:07 AM
News IconStocks in Queue: Twitter Inc (NYSE:TWTR), Gilead Sciences, Inc ... - NYSE Journal (press release) (NASDAQ:GILD)
stockznews.com - August 18 at 5:13 PM
News IconGilead Sciences Inc.'s (GILD): Market Traders Alert - Hot Stocks Point (NASDAQ:GILD)
www.hotstockspoint.com - August 18 at 5:13 PM
thecountrycaller.com logoWould Gilead Sciences, Inc. (GILD) Need to Split up to Survive? - TCC (NASDAQ:GILD)
www.thecountrycaller.com - August 18 at 5:13 PM
News IconBiotech Stocks Worth a Closer Look: Gilead Sciences Inc. (NASDAQ:GILD), Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) - The Voice Registrar (NASDAQ:GILD)
voiceregistrar.com - August 18 at 8:11 AM
News IconTop Gainers of the Day: Gilead Sciences Inc. (NASDAQ:GILD) from Biotechnology (NASDAQ:GILD)
twincountynews.com - August 17 at 5:28 PM
blogs.barrons.com logoGilead Sciences: Still Dominating Hepatitis C But… (NASDAQ:GILD)
blogs.barrons.com - August 17 at 5:28 PM
finance.yahoo.com logoGilead: Why A Split Up Is Much Needed For Turnaround Growth? (NASDAQ:GILD)
finance.yahoo.com - August 17 at 5:28 PM
finance.yahoo.com logoWhich stocks will soar 50% over the next year? (NASDAQ:GILD)
finance.yahoo.com - August 17 at 5:28 PM
investors.com logoMerck Among Drug Giants Looking To Buy Medivation, Says Report (NASDAQ:GILD)
www.investors.com - August 17 at 5:28 PM
News IconBiotechnology Stocks to Lookout: Gilead Sciences, Inc. (NASDAQ:GILD), Ocular Therapeutix Inc (NASDAQ:OCUL) - Post Registrar (NASDAQ:GILD)
postregistrar.com - August 17 at 8:14 AM
bidnessetc.com logoGilead Sciences, Inc. (GILD) Stock: Piper Jaffray Sees Effortless 40% Upside - Bidness ETC (NASDAQ:GILD)
www.bidnessetc.com - August 17 at 8:14 AM
seekingalpha.com logoGilead's Next Move Should Be Higher (NASDAQ:GILD)
seekingalpha.com - August 16 at 5:23 PM
smarteranalyst.com logoGilead Sciences, Inc. (GILD) Is Our Top Large Cap Pick: Piper Jaffray (NASDAQ:GILD)
www.smarteranalyst.com - August 16 at 5:23 PM
smarteranalyst.com logoGilead Sciences, Inc. (GILD) Is Our Top Large Cap Pick: Piper Jaffray - Smarter Analyst (NASDAQ:GILD)
www.smarteranalyst.com - August 16 at 8:34 AM
fool.com logo4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer (NASDAQ:GILD)
www.fool.com - August 16 at 8:34 AM
News IconMacy’s Inc (NYSE:M) & Gilead Sciences, (NASDAQ:GILD) Are Stocks to Keep Your Eyes on (NASDAQ:GILD)
www.newsismoney.com - August 15 at 5:24 PM
investors.com logoBuffett's Berkshire Ups Apple Stake As Others Sold iPhone Maker, Netflix (NASDAQ:GILD)
www.investors.com - August 15 at 5:24 PM
fool.com logoThese 3 Hated Dividend Stocks Look Like Buys (NASDAQ:GILD)
www.fool.com - August 14 at 9:51 AM
News Icon7 Battered Biotech Stocks to Buy (NASDAQ:GILD)
portal.kiplinger.com - August 14 at 9:51 AM
fool.com logoCould Gilead Sciences Face an Unexpected $10 Billion Tax Bill? (NASDAQ:GILD)
www.fool.com - August 13 at 2:43 PM
News IconStock on Trader's Radar: Gilead Sciences, Inc. (NASDAQ:GILD) - Post Registrar (NASDAQ:GILD)
postregistrar.com - August 13 at 8:08 AM
thecountrycaller.com logoWill Gilead Sciences, Inc. (GILD) Survive This Roller-Coaster Ride? - TCC (NASDAQ:GILD)
www.thecountrycaller.com - August 12 at 5:17 PM
finance.yahoo.com logoGILEAD SCIENCES INC Financials (NASDAQ:GILD)
finance.yahoo.com - August 12 at 5:17 PM
blogs.barrons.com logoGilead Sciences: The Pressure is (Still) On (NASDAQ:GILD)
blogs.barrons.com - August 12 at 5:17 PM
thestreet.com logoGilead Could Be Better off Splitting Drug Businesses -- RBC Capital (NASDAQ:GILD)
www.thestreet.com - August 12 at 5:17 PM
thestreet.com logoHow Will Gilead (GILD) Stock React to Hepatitis-C Drug Prescriptions? (NASDAQ:GILD)
www.thestreet.com - August 12 at 5:17 PM
thecountrycaller.com logoHere's Why Gilead Sciences, Inc.(NASDAQ:GILD) Would Pay $5 Million to Genmab A/S - TCC (NASDAQ:GILD)
www.thecountrycaller.com - August 12 at 8:15 AM

Social

Gilead Sciences (NASDAQ:GILD) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff